TD Asset Management
BBNX

TD Asset Management’s Beta Bionics BBNX Stock Holding History

TD Asset Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,274
Closed -$193K – 1336
2026
Q1 		$193K Sell
19,274
-46,602
-71% -$689K ﹤0.01% 1223
2025
Q4 		$2.01M Buy
65,876
+5,800
+10% +$155K ﹤0.01% 981
2025
Q3 		$1.19M Buy
60,076
+20,200
+51% +$355K ﹤0.01% 1061
2025
Q2 		$581K Hold
39,876
– – ﹤0.01% 1119
2025
Q1 		$488K Buy
+39,876
New +$743K ﹤0.01% 1147

Other funds holding BBNX

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TD Asset Management's BBNX Position: Q2 2026 in Review

TD Asset Management sold out of Beta Bionics (BBNX) in Q2 2026, closing a stake of 19,274 shares — an estimated $193K sold.

TD Asset Management first reported a position in BBNX in Q1 2025 and held it in 5 quarters. The position peaked at $2.01M in Q4 2025. 83 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • TD Asset Management reported no remaining Beta Bionics position as of Q2 2026 after selling out during the quarter.
  • TD Asset Management sold 19,274 Beta Bionics shares in Q2 2026, an estimated $193K.
  • TD Asset Management first reported a position in Beta Bionics in Q1 2025 and held it in 5 quarters.
  • TD Asset Management's Beta Bionics position peaked at $2.01M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.